Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta

被引：82
作者：
Batocchi, AP
Rotondi, M
Caggiula, M
Frisullo, G
Odoardi, F
Nociti, V
Carella, C
Tonali, PA
Mirabella, M
机构：
[1] Catholic Univ, Neurol Inst, I-00168 Rome, Italy
[2] Univ Naples, F Magrassi Inst Endocrinol II, Dept Clin & Expt Med, I-80121 Naples, Italy
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2003年 / 139卷 / 1-2期
关键词：
leptin; cytokines; multiple sclerosis; interferon beta;
D O I：
10.1016/S0165-5728(03)00154-1
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The role of leptin was investigated in relapsing-remitting multiple sclerosis (MS). Control and MS patients showed comparable baseline serum leptin levels. During the first year of IFNbeta-1a treatment, leptin significantly decreased since 2 months after starting therapy in 11 patients who had no relapses. A significant decrease in IL12/IL10 ratio was observed in this group of patients only after I year of treatment. An increase of leptin was observed before the first clinical exacerbation in 13 relapsing patients. Leptin may play a pathogenic role in MS and can be a useful marker of disease activity and response to therapy. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码：150 / 154
页数：5
相关论文
共 16 条
[1]   Interferon-β therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 production [J].
Byrnes, AA ;
McArthur, JC ;
Karp, CL .
ANNALS OF NEUROLOGY, 2002, 51 (02) :165-174
[2]   Considerations in the treatment of relapsing-remitting multiple sclerosis [J].
Calabresi, PA .
NEUROLOGY, 2002, 58 (08) :S10-S22
[3]   Leptin and the regulation of body weight in mammals [J].
Friedman, JM ;
Halaas, JL .
NATURE, 1998, 395 (6704) :763-770
[4]   Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse [J].
Gayo, A ;
Mozo, L ;
Suárez, A ;
Tuñon, TB ;
Lahoz, C ;
Gutiérrez, C .
JOURNAL OF NEUROIMMUNOLOGY, 1998, 85 (02) :122-130
[5]   Serial analysis of cytokine mRNA profiles in whole blood samples from patients with early multiple sclerosis [J].
Kahl, KG ;
Kruse, N ;
Toyka, KV ;
Rieckmann, P .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 200 (1-2) :53-55
[6]   Leptin regulates proinflammatory immune responses [J].
Loffreda, S ;
Yang, SQ ;
Lin, HZ ;
Karp, CL ;
Brengman, ML ;
Wang, DJ ;
Klein, AS ;
Bulkley, GB ;
Bao, C ;
Noble, PW ;
Lane, MD ;
Diehl, AM .
FASEB JOURNAL, 1998, 12 (01) :57-65
[7]   Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression [J].
Lord, GM ;
Matarese, G ;
Howard, LK ;
Baker, RJ ;
Bloom, SR ;
Lechler, RI .
NATURE, 1998, 394 (6696) :897-901
[8]   Glucocorticoid regulation of leptin synthesis and secretion in humans: Elevated plasma leptin levels in Cushing's syndrome [J].
Masuzaki, H ;
Ogawa, Y ;
Hosoda, K ;
Miyawaki, T ;
Hanaoka, I ;
Hiraoka, J ;
Yasuno, A ;
Nishimura, H ;
Yoshimasa, Y ;
Nishi, S ;
Nakao, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (08) :2542-2547
[9]   Balancing susceptibility to infection and autoimmunity: a role for leptin? [J].
Matarese, G ;
La Cava, A ;
Sanna, V ;
Lord, GM ;
Lechler, RI ;
Fontana, S ;
Zappacosta, S .
TRENDS IN IMMUNOLOGY, 2002, 23 (04) :182-187
[10]   Requirement for leptin in the induction and progression of autoimmune encephalomyelitis [J].
Matarese, G ;
Di Giacomo, A ;
Sanna, V ;
Lord, GM ;
Howard, JK ;
Di Tuoro, A ;
Bloom, SR ;
Lechler, RI ;
Zappacosta, S ;
Fontana, S .
JOURNAL OF IMMUNOLOGY, 2001, 166 (10) :5909-5916
12